Melanocytic naevi of other and unspecified parts of face

CD2_BENIGN_MELANOCYTIC_FACE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 D22.3&
Hospital discharge: ICD-9 2163A
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 D22.3&
Cause of death: ICD-9 2163A
Cause of death: ICD-8 $!$

1247

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

1247

diagram downward connector

Check minimum number of events None

1247

diagram downward connector

Include endpoints None

1247

diagram downward connector
CD2_BENIGN_MELANOCYTIC_FACE

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D22
Name in latin Naevus melanocyticus (cutis) faciei

Summary Statistics

Key figures

All Female Male
Number of individuals 1203 835 368
Unadjusted prevalence (%) 0.39 0.48 0.27
Mean age at first event (years) 48.48 45.92 54.29

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.02 1.62 [0.98, 2.68] 5.9e-2 55
15 years 0.01 1.00 [0.58, 1.71] 1.0e+0 32
5 years 0.00 1.28 [0.65, 2.52] 4.7e-1 15
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: CD2_BENIGN_MELANOCYTIC_FACE – Melanocytic naevi of other and unspecified parts of face
GWS hits: 0

Survival analyses between endpoints

Plot

before Melanocytic naevi of other and unspecified parts of face
after Melanocytic naevi of other and unspecified parts of face

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Melanocytic naevi of other and unspecified parts of face